logo
Select company
Select metric
$ 3.63MNet Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
29
Sector
52
Industry
31
History
25
$ 2.2Close
$ 1.38 - $ 5.6 52-Week Range
Ticker Information

Ticker

MGRX

Company Name

MANGOCEUTICALS INC

Sector

Healthcare

Industry

Health Information Services

Exchange

NASDAQ

MANGOCEUTICALS INC - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MGRX - CF - Equity Historical data
DateNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025$ 3.63M
3/31/2025$ 2.28M
12/31/2024$ 1.33M
9/30/2024$ 1.77M
6/30/2024$ 1.77M
3/31/2024$ 2.4M
12/31/2023$ 7.22M
9/30/2023$ 6.52M
12/31/2022$ 2M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MANGOCEUTICALS INC's latest trailing twelve months (TTM) CF - Equity stands at $ 2M.
  • Over the past 5 years, MANGOCEUTICALS INC's average CF - Equity has been $ 3.21M.
  • The median CF - Equity for MANGOCEUTICALS INC during this period was $ 2.28M
  • MANGOCEUTICALS INC reached its highest CF - Equity over the past 5 years at $ 7.22M.
  • The lowest CF - Equity recorded by MANGOCEUTICALS INC in the same timeframe $ 1.33M

MANGOCEUTICALS INC's CF - Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Equity Benchmarks
CompanyCF - Equity
ONMD : ONEMEDNET CORP $ 9.76MLEXX : LEXARIA BIOSCIENCE CORP $ 6.05MIBIO : IBIO INC $ 3.67MERNA : ERNEXA THERAPEUTICS INC $ 5.93MPULM : PULMATRIX INC $ 0BRTX : BIORESTORATIVE THERAPIES INC $ 2.05MBFRG : BULLFROG AI HOLDINGS INC $ 2.9MVYNE : VYNE THERAPEUTICS INC $ 0ADGM : ADAGIO MEDICAL HOLDINGS INC $ 0NXL : NEXALIN TECHNOLOGY INC $ 4.52M

Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).

MGRX - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years

$ 1.33M

Minimum

Dec 31, 2024

$ 7.22M

Maximum

Dec 31, 2023

$ 3.21M

Average

$ 2.28M

Median

CF - Equity Benchmark Analysis

The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 107.22K with a standard deviation of $ 17.65M.
The following table provides additional summary stats:
CF - Equity in the Market:
filtered constituents2.89K
min$ -60.59M
max$ 60.64M
average$ 107.22K
median$ 0
std$ 17.65M